Consensus guidelines for the management of plaque psoriasis.

Abstract

The Canadian Guidelines for the Management of Plaque Psoriasis were reviewed by the entire National Psoriasis Foundation Medical Board and updated to include newly approved agents such as ustekinumab and to reflect practice patterns in the United States, where the excimer laser is approved for psoriasis treatment. Management of psoriasis in special populations is discussed. In the updated guidelines, we include sections on children, pregnant patients or pregnant partners of patients, nursing mothers, the elderly, patients with hepatitis B or C virus infections, human immunodeficiency virus-infected patients, and patients with malignant neoplasms, as well as sections on tumor necrosis factor blockers, elective surgery, and vaccinations.

• Authors: Sylvia Hsu, Kim Alexander Papp, Mark G Lebwohl, Jerry Bagel, Andrew Blauvelt, Kristina Callis Duffin, Jeffrey Crowley, Lawrence F Eichenfield, Steven R Feldman, David F Fiorentino, Joel M Gelfand, Alice B Gottlieb, Carmen Jacobsen, Robert E Kalb, Arthur Kavanaugh, Neil J Korman, Gerald G Krueger, Melissa A Michelon, Warwick Morison, Christopher T Ritchlin, Linda Stein Gold, Stephen P Stone, Bruce E Strober, Abby S Van Voorhees, Stefan C Weiss, Karolyn Wanat, Bruce F Bebo Jr, National Psoriasis Foundation Medical Board
• Journal: Archives of dermatology (Arch Dermatol) Vol. 148 Issue 1 Pg. 95-102 (Jan 2012) ISSN: 1538-3652 [Electronic] United States
• PMID: 22250239 (Publication Type: Journal Article, Practice Guideline, Research Support, Non-U.S. Gov't)

Topics

• Humans
• Psoriasis (complications, therapy)
• Severity of Illness Index